What is the global market size of Regenerative Medicine Market?

Regenerative Medicine Market size was valued at USD 9.59 billion in 2021 and is poised to grow from USD 12.2 billion in 2022 to USD 83.6 billion by 2030, growing at a CAGR of 27.2% in the forecast period (2023-2030).

Regenerative Medicine Market Size, Share, Growth Analysis, By Product(Therapeutics, stem cell & progenitor cell-based therapeutics and services), By Therapeutic Category(Dermatology, musculoskeletal), By Distribution Channel(Hospitals, clinics and others) - Industry Forecast 2024-2031

Q: Who are the key vendors in the Global Regenerative Medicine Market?

The global regenerative medicine market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Integra Lifesciences Holdings Corporation', 'Organogenesis Inc.', 'Vericel Corporation', 'NuVasive, Inc.', 'Osiris Therapeutics, Inc.', 'Acelity L.P. Inc. (KCI)', 'Stryker Corporation', 'Medtronic PLC', 'Baxter International Inc.', 'Zimmer Biomet Holdings, Inc.', 'Allergan PLC (AbbVie Inc.)', 'Smith & Nephew PLC', 'MiMedx Group, Inc.', 'Integra Holdings', 'Mimedx Group', 'Misonix, Inc.', 'Cryolife, Inc.', 'Terumo Corporation', 'Orthofix Medical Inc.', 'Wright Medical Group N.V.'

Q: What is the key market trend for Global Regenerative Medicine Market?

One of the dominant trends in the global market for regenerative medicine is the use of strategic acquisitions by major companies to increase their R&D capabilities. Products in this market include unique techniques developed from living cells and proteins, enzymes, antibodies, antibody-drug conjugates (ADC), and genes and cellular components that lead to lifesaving drugs for a variety of chronic diseases. However, when it comes to putting these technologies into clinical practice, there can be a discrepancy between aspirations and reality. Some significant businesses are focusing on acquisitions to boost their R&D capabilities to bridge this gap and develop research into diverse clinical applications.

Q: Which region accounted for the largest share in Global Regenerative Medicine Market?

North America dominated the global market in 2021, accounting for more than 45% of the total revenue. This is due to the presence of a large number of major players in the United States. The presence of research institutions interested in the development of innovative treatments, as well as the availability of advanced technologies, contributes to a large number of clinical trials in the region. Financial availability, as well as many initiatives by government and private organizations, contributes to the largest revenue stream from the United States. For example, the US The Department of Health and Human Services 2020 A New Vision, campaign places regenerative medicine at the forefront of healthcare.

Report ID: SQMIG35I2129 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

Regenerative Medicine Market News

In June 2022, Bristol Myers Squibb Company received FDA approval for CAR T cell Therapy Breyanzi. It is for people who cannot receive a transplant and have primary refractory or relapsed large B-cell lymphoma (LBCL).

In June 2022, Avista Therapeutics announced collaboration with F. Hoffmann La Roche Ltd to develop innovative AAV gene therapy vectors for eye disorders.

In April 2022, Kite, a Gilead Company, got FDA approval for Yescarta CAR T-cell therapy to treat adult patients with large B-cell lymphoma.

In March 2022, Novartis and Voyager Therapeutics signed a licensing option agreement for next-generation gene therapy vectors for neurological diseases.

In February 2022, Santhera Pharmaceuticals and SEAL Therapeutics signed a strategic partnership agreement to work on the development of gene therapies for LAMA2-deficient congenital muscular dystrophy (LAMA2 MD).

Regenerative Medicine Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Regenerative Medicine Market size was valued at USD 9.59 billion in 2019 and is poised to grow from USD 12.2 billion in 2023 to USD 83.6 billion by 2031, growing at a CAGR of 27.2% in the forecast period (2024-2031).

The regenerative medicine market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Integra Lifesciences Holdings Corporation', 'Organogenesis Inc.', 'Vericel Corporation', 'NuVasive, Inc.', 'Osiris Therapeutics, Inc.', 'Acelity L.P. Inc. (KCI)', 'Stryker Corporation', 'Medtronic PLC', 'Baxter International Inc.', 'Zimmer Biomet Holdings, Inc.', 'Allergan PLC (AbbVie Inc.)', 'Smith & Nephew PLC', 'MiMedx Group, Inc.', 'Integra Holdings', 'Mimedx Group', 'Misonix, Inc.', 'Cryolife, Inc.', 'Terumo Corporation', 'Orthofix Medical Inc.', 'Wright Medical Group N.V.'

The growing investment in this market has resulted in complete research and development activities, as various investors support start-up companies that focus on the development of new treatments and products in the market. This has paved the way for large-scale mergers, research collaborations, and partnerships to profit from R&D operations. Apart from private players, various government and government-funded research institutes are actively investing in this industry to introduce effective treatment options for various chronic diseases like cancer, Parkinson's disease, diabetes, kidney disease, cardiovascular disease, and others.

One of the dominant trends in the market for regenerative medicine is the use of strategic acquisitions by major companies to increase their R&D capabilities. Products in this market include unique techniques developed from living cells and proteins, enzymes, antibodies, antibody-drug conjugates (ADC), and genes and cellular components that lead to lifesaving drugs for a variety of chronic diseases. However, when it comes to putting these technologies into clinical practice, there can be a discrepancy between aspirations and reality. Some significant businesses are focusing on acquisitions to boost their R&D capabilities to bridge this gap and develop research into diverse clinical applications.

North America dominated the market in 2021, accounting for more than 45% of the total revenue. This is due to the presence of a large number of major players in the United States. The presence of research institutions interested in the development of innovative treatments, as well as the availability of advanced technologies, contributes to a large number of clinical trials in the region. Financial availability, as well as many initiatives by government and private organizations, contributes to the largest revenue stream from the United States. For example, the US The Department of Health and Human Services 2020 A New Vision, campaign places regenerative medicine at the forefront of healthcare.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Regenerative Medicine Market Size, Share, Growth Analysis, By Product(Therapeutics, stem cell & progenitor cell-based therapeutics and services), By Therapeutic Category(Dermatology, musculoskeletal), By Distribution Channel(Hospitals, clinics and others) - Industry Forecast 2024-2031

Regenerative Medicine Market News

Regenerative Medicine Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Regenerative Medicine Market?

Who are the key vendors in the Regenerative Medicine Market?

What is the key driver of Regenerative Medicine Market?

What is the key market trend for Regenerative Medicine Market?

Which region accounted for the largest share in Regenerative Medicine Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300